Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy as First-line Treatment Against Helicobacter Pylori

NCT05301725 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT05301725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05301725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy as First-line Treatment Against Helicobacter Pylori
Lead sponsor
Shandong University
Phase
Observational
Overall status
Completed
Start date
July 1, 2018
Completion date
December 31, 2021
Enrollment
670 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori; eradication rate